Tubedown-1 in remodeling of the developing vitreal vasculature in vivo and regulation of capillary outgrowth in vitro

Developmental Biology

Volumn 249, Issue 1, 2002, Pages 140-155

  Paradis, H ^a   Liu, C Y ^b   Saika, S ^b   Azhar, M ^b   Doetschman, T ^b   Good, W V ^c   Nayak, R ^d   Laver, N ^d   Kao, C C ^b   Kao, W Y ^b   Gendron, R L ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c SMITH KETTLEWELL EYE RESEARCH INSTITUTE   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

Capillary outgrowth; Endothelium; Pericyte; TGF 2; Tubedown 1; Vitreal vasculature

Indexed keywords

ACYLTRANSFERASE; ALPHA ACTIN; COLLAGEN TYPE 4; COMPLEMENTARY DNA; CYCLINE; MICROSOMAL AMINOPEPTIDASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN TUBEDOWN 1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CELL DENSITY; CHOROID; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ULTRASTRUCTURE; VASCULARIZATION; VITREOUS BODY;

LAMIINAE; MAMMALIA; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 18644378330     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.2002.0757     Document Type: Article

References (62)

1. Addison, D. J., Garner, A., and Ashton, N. (1970). Degeneration of intramural pericytes in diabetic retinopathy. Br. Med. J. 691, 264-266.
2. Alliot, F., Rutin, J., Leenen, P. J., and Pessac, B. (1999). Pericytes and periendothelial cells of brain parenchyma vessels co-express aminopeptidase N, aminopeptidase A, and nestin. J. Neurosci. Res. 58, 367-378.
3. Antonelli-Orlidge A., Saunders, K. B., Smith, S. R., and D'Amore, P. A. (1989). An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 86, 4544-4548.
4. Ash, J. D., and Overbeek, P. A. (2000). Lens-specific VEGF-A expression induces angioblast migration and proliferation and stimulates angiogenic remodeling. Dev. Biol. 223, 383-398.
5. Ashton, N. (1974). Vascular basement membrane changes in diabetic retinopathy. Montgomery lecture, 1973. Br. J. Ophthalmol. 58, 344-366.
6. Bloodworth, J. M., Jr., and Epstein, M. (1967). Diabetic amyotrophy. Light and electron microscopic investigation. Diabetes 16, 181-190.
7. Boeve, M. H., van der Linde-Sipman, J. S., Stades, F. C., and Vrensen, G. F. (1990). Early morphogenesis of persistent hyper-plastic tunica vasculosa lentis and primary vitreous. A transmission electron microscopic study. Invest. Ophthalmol. Vis. Sci. 31, 1886-1894.
8. Castillo, M., Wallace, D. K., and Mukherji, S. K. (1997). Persistent hyperplastic primary vitreous involving the anterior eye. AJNR Am. J. Neuroradiol. 18, 1526-1528.
9. Cogan, D. G., and Kuwabara, T. (1967). The mural cell in perspective. Arch. Ophthalmol. 78, 133-139.
10. Dhanasekaran, N., and Premkumar Reddy, E. (1998). Signaling by dual specificity kinases. Oncogene 17, 1447-1455.
11. Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S., and Akhurst, R. J. (1995). Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121, 1845-1854.
12. Dunker, N., and Krieglstein, K. (2000). Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur. J. Biochem. 267, 6982-6988.
13. Feinberg, A. P., and Vogelstein, B. (1983). A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13.
14. Gendron, R. L., Adams, L. C., and Paradis, H. (2000). Tubedown-1, a novel acetyltransferase associated with blood vessel development. Dev. Dyn. 218, 300-315.
15. Gendron, R. L., Good, W. V., Adams, L. C., and Paradis, H. (2001a). Expression of tubedown-1 is suppressed in retinal neovascularization of proliferative diabetic retinopathy. Invest. Opthalmol. Vis. Sci. 42, 3000-3007.
16. Gendron, R. L., Liu, C.-Y., Paradis, H., Adams, L. C., and Kao. W.-W.-Y. (2001b). MK/T-1, an immortalized fibroblast cell line derived using cultures of mouse corneal stroma. Mol. Vis. 7, 107-113.
17. Gendron, R. L., Tsai, F. Y., Paradis, H., and Arceci, R. J. (1996). Induction of embryonic vasculogenesis by bFGF and LIF in vitro and in vivo. Dev. Biol. 177, 332-346.
18. Goldberg, M. F. (1997). Persistent fetal vasculature (PFV): An integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PFV). LIV Edward Jackson Memorial Lecture. Am. J. Ophthalmol. 124, 587-626.
19. Hall, P. A., Levison, D. A., Woods, A. L., Yu, C. C., Kellock, D. B., Watkins, J. A., Barnes, D. M., Gillett, C. E., Camplejohn, R., Dover, R., et al. (1990). Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol. 162, 285-294.
20. Hammes, H. P., Lin, J., Bretzel, R. G., Brownlee, M., and Breier, G. (1998). Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 47, 401-406.
21. Hayasaka, K., Oikawa, S., Hashizume, E., Kotake, H., Midorikawa, H., Sekikawa, A., Hoshi, K., Hara, S., Ishigaki, Y., and Toyota, T. (1998). Anti-angiogenic effect of TGFbeta in aqueous humor. Life Sci. 63, 1089-1096.
22. Hellstrom, M., Gerhardt, H., Kalen, M., Li, X., Eriksson, U., Wolburg, H., and Betsholtz, C. (2001). Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 153, 543-553.
23. Hirschi, K. K., and D'Amore, P. A. (1997). Control of angiogenesis by the pericyte: molecular mechanisms and significance. EXS 79, 419-428.
24. Hirschi, K. K., Rohovsky, S. A., Beck, L. H., Smith, S. R., and D'Amore, P. A. (1999). Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ. Res. 84, 298-305.
25. Hirschi, K. K., Rohovsky, S. A., and D'Amore, P. A. (1998). PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 141, 805-814.
26. Ito, M., and Yoshioka, M. (1999). Regression of the hyaloid vessels and pupillary membrane of the mouse. Anat. Embryol. (Berl.) 200, 403-411.
27. Lang, R. A., and Bishop, J. M. (1993). Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell 74, 453-462.
28. Lazarus, H. S., and Hageman, G. S. (1994). In situ characterization of the human hyalocyte. Arch. Ophthalmol. 112, 1356-1362.
29. Lou, D. A., and Hu, F. N. (1987a). Co-distribution of von Willebrand factor and fibronectin in cultured rhesus endothelial cells. Histochem. J. 19, 431-438.
30. Lou, D. A., and Hu, F. N. (1987b). Specific antigen and organelle expression of a long-term rhesus endothelial cell line. In Vitro Cell Dev. Biol. 23, 75-85.
31. McCright, B., Gao, X., Shen, L., Lozier, J., Lan, Y., Maguire, M., Herzlinger, D., Weinmaster, G., Jiang, R., and Gridley, T. (2001). Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 128, 491-502.
32. Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N. P. H., Risau, W., and Ullrich, A. (1993). High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846.
33. Mitchell, C. A., Risau, W., and Drexler, H. C. (1998). Regression of vessels in the tunica vasculosa lentis is initiated by coordinated endothelial apoptosis: A role for vascular endothelial growth factor as a survival factor for endothelium. Dev. Dyn. 213, 322-333.
34. Mullen, J. R., Kayne, P. S., Moerschell, R. P., Tsunasawa, S., Gribskov, M., Colavito-Shepanski, M., Grunstein, M., Sherman, F., and Sternglanz, R. (1989). Identification and characterization of genes and mutants for an N-terminal acetyltransferase from yeast. EMBO J. 8, 2067-2075.
35. 41/43 MAP kinase. J. Cell Sci. 113, 4331-4339.
36. Park, E. C., and Szostak, J. W. (1992). ARD1 and NAT1 proteins form a complex that has N-terminal acetyltransferase activity. EMBO J. 11, 2087-2093.
37. Piek, E., Heldin, C. H., and Ten Dijke, P. (1999). Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J. 13, 2105-2124.
38. Podesta, F., Romeo, G., Liu, W. H., Krajewski, S., Reed, J. C., Gerhardinger, C., and Lorenzi, M. (2000). Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am. J. Pathol. 156, 1025-1032.
39. RayChaudhury, A., and D'Amore, P. A. (1991). Endothelial cell regulation by transforming growth factor-beta. J. Cell Biochem. 47, 224 -229.
40. Reichel, M. B., Ali, R. R., D'Esposito, F., Clarke, A. R., Luthert, P. J., Bhattacharya, S. S., and Hunt, D. M. (1998). High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ. 5, 156-162.
41. Robbins, S. G., Rajaratnam, V. S., and Penn, J. S. (1998). Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors flt-1 and flk-1 in the oxygen-injured rat retina. Growth Factors 16, 1-9.
42. Saika, S., Saika, S., Liu, C.-Y., Sanford, L. P., Azhar, M., Doetschman, T., Gendron, R. L., Kao, C. W.-C., and Kao, W. W.-Y (2001). TGFb2 is involved in corneal morphogenesis during mouse embryonic development. Dev. Biol. 240, 419-432.
43. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). "Molecular Cloning: A Laboratory Manual," 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
44. Sanford, L. P., Ormsby, I., Gittenberger-de Groot, A. C., Sariola, H., Friedman, R., Boivin, G. P., Cardell, E. L., and Doetschman, T. (1997). TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124, 2659-2670.
45. Sarthy, V. (1993). Collagen IV mRNA expression during development of the mouse retina: An in situ hybridization study. Invest. Ophthalmol. Vis. Sci. 34, 145-152.
46. Sato, Y., and Rifkin, D. B. (1989). Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J. Cell Biol. 109, 309-315.
47. Sawtell, N. M., and Lessard, J. L. (1989). Cellular distribution of smooth muscle actins during mammalian embryogenesis: Expression of the alpha-vascular but not the gamma-enteric isoform in differentiating striated myocytes. J. Cell. Biol. 109, 2929-2937.
48. Schlatt, S., Weinbauer, G. F., Arslan, M., and Nieschlag, E. (1993). Appearance of alpha-smooth muscle actin in peritubular cells of monkey testes is induced by androgens, modulated by follicle-stimulating hormone, and maintained after hormonal withdrawal. J. Androl. 14, 340-350.
49. Schor, A. M., and Schor, S. L. (1986). The isolation and culture of endothelial cells and pericytes from the bovine retinal microvas-culature: A comparative study with large vessel vascular cells. Microvasc. Res. 32, 21-38.
50. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A. C. (1995). Failure of blood island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.
51. Silbert, M., and Gurwood, A. S. (2000). Persistent hyperplastic primary vitreous. Clin. Eye Vis. Care. 12, 131-137.
52. Speiser, P., Gittelsohn, A. M., and Patz, A. (1968). Studies on diabetic retinopathy. 3. Influence of diabetes on intramural pericytes. Arch. Ophthalmol. 80, 332-337.
53. Spranger, J., Meyer-Schwickerath, R., Klein, M., Schatz, H., and Pfeiffer, A. (1999). Deficient activation and different expression of transforming growth factor-beta isoforms in active proliferative diabetic retinopathy and neovascular eye disease. Exp. Clin. Endocrinol. Diabetes 107, 21-28.
54. Srinivasan, Y., Lovicu, F. J., and Overbeek, P. A. (1998). Lens-specific expression of transforming growth factor beta1 in transgenic mice causes anterior subcapsular cataracts. J. Clin. Invest. 101, 625-634.
55. Steichen-Gersdorf, E., Gassner, I., Unsinn, K., and Sperl, W. (1997). Persistent hyperplastic primary vitreous in a family with osteoporosis-pseudoglioma syndrome. Clin. Dysmorphol. 6, 171-176.
56. Takahashi, T., and Shibuya, M. (1997). The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 14, 2079-2089.
57. Verbeek, M. M., Otte-Holler, I., Wesseling, P., Ruiter, D. J., and de Waal, R. M. (1994). Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta Am. J. Pathol. 144, 372-382.
58. Wakui, S. (1992). Epidermal growth factor receptor at endothelial cell and pericyte interdigitation in human granulation tissue. Microvasc. Res. 44, 255-262.
59. Yang, K., and Cepko, C. L. (1996). Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J. Neurosci. 16, 6089-6099.
60. Yamaguchi, T. P., Dumont, D. J., Conlon, R. A., Breitman, M. L., and Rossant, J. (1993). flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118, 489-498.
61. Yanoff, M. (1966). Diabetic retinopathy. N. Engl. J. Med. 274, 1344-1349.
62. Zhu, M., Provis, J. M., and Penfold, P. L. (1999). The human hyaloid system: cellular phenotypes and inter-relationships. Exp. Eye Res. 68, 553-563.